[ET Net News Agency, 31 March 2021] Viva Biotech Holdings (01873) said its loss
attributable to owners of the parent was RMB386.88 million for the year ended 31 December
2020, compared to the profit of RMB265.87 million of the same period last year. The basic
loss per share was RMB0.25. A final dividend of HK$0.01 will be distributed.
The revenue was RMB696.96 million, a year-on-year increase of 115.74%. (RC)